According to a market report by Lucintel, the future of the global cardiovascular device market looks promising with opportunities in the pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, electrocardiogram, and event monitor markets. The global cardiovascular device market is expected to reach an estimated $146,482 million by 2035 with a CAGR of 5.2% from 2025 to 2035. The major drivers for this market are the rising demand for minimally invasive procedures, the growing adoption of advanced medical technology, and the increasing demand for wearable & remote monitoring devices.
A more
than 150-page report to understand trends, opportunity and forecast in global cardiovascular
device market to 2035 by type (cardiac rhythm management, interventional
cardiac devices, peripheral vascular devices, cardiac assist devices,
structural heart devices, cardiovascular surgery, electrophysiology, and
diagnostic & monitoring devices), device (pacemaker, defibrillator, stent,
cardiac catheter, guidewire, heart valve, electrocardiogram, event monitor, and
others), and region (North America, Europe, Asia Pacific, and the Rest of the
World).
Lucintel
forecasts that, within the type category, interventional cardiac device is
expected to witness the highest growth over the forecast period.
Within the
device category, stent is expected to witness the highest growth.
Download
sample by clicking on cardiovascular
device market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Abbott
Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation,
Medtronic Public Limited Company, C. R. Bard, Inc., Johnson & Johnson, St.
Jude Medical Inc., Cook Medical Inc., Terumo Corporation, Cardinal Health Inc. are
the major suppliers in the cardiovascular
device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Enterprise IT Asset Disposition Market